pharmaceuticalethics, pharma, compliance, clinical, app, health, digipharm, pharma engagement live

Clinical, moral and compliance dilemmas in health app development

Nick Broughton, Managing Director of Pharmaceuticalethics.com gives his presentation on ‘Clinical, moral and compliance dilemmas in health app development’ at DigiPharm 2013.  Watch the full video. Interested in learning more?  Join us at Pharma Engagement Live 2014, held this 7-8 October in London at the Business Design Centre.  Explore the issues involved in engaging, supporting and educating both patients, carers and …

Today and tomorrow’s world – not-for-profits join with industry to develop drugs

I’ve had several conversations with pharmaceutical industry experts in the last few days. There seems to be increasing interest from sponsors marrying up with research charities. I thought that I would share some examples with you. Cancer Research UK developed Clinical Development Partnerships (CDP) meaning that de-prioritised agents can be given a second chance. The initiative also opens the door …

Top 5 Trends in Clinical Partnering and Outsourcing

  Clinical Outsourcing and Partnering is entering a new age of popularity and it looks set to prosper. A report by Transparency Market Research indicates that the outsourced research market is expected to be worth $65.03 billion by 2018. Since the 1980s, more and more pharma, biopharma and biotechs have turned to clinical outsourcing and partnering. As the agenda for …

The Current Phase I Landscape

  Can we more efficiently translate our growing biological understanding of cancer into relevant novel treatments?  That is what Dr Bruno Osterwalder, Senior VP, Senior Strategic Advisor Oncology, Merck Serono, Darmstadt, Germany discussed during his presentation at the Exploratory Clinical Development World Europe event held last year. In his presentation, “The Current Phase I Landscape,” Dr Osterwalder covers: Attrition in Phase III Continues …

The Gamida Cell Chronicles: Diary of a Clinical Adventure

Yael Margolin, Gamida joined us last year at the World Stem Cells & Regenerative Medicine Congress to present on ‘The Gamida Cell Chronicles: Diary of a Clinical Adventure.’ Download this presentation now to find out more about: Promising Pipeline of Stem Cell Therapies Target Market in Hematological Malignancies Umbilical Cord Blood (UCB) is an Alternative Source of Hematopoietic Stem Cells …

Download: Top challenges in assessing the safety for a new compound

At Exploratory Clinical Development World Europe 2013, we gathered several high level attendees and produced video interviews discussing the topic: “What are the challenges in assessing the safety for a new compound?” These video interviews have been gathered and presented in the following ebook and contain feedback from: Maria Hernandez Fuentes, Kings College London Fred Pritchard, Celerion James Dow, Daiichi …

Vbook: How can the industry work with payers to ensure that the best treatments get to patients?

      Ensuring that your medicines get to the patients that need them involves dealing with clinicians, payers, HTA bodies and internal and external stakeholders. Just as you think you understand the rules of the game, they change. We asked a number of acknowledged thought leaders their view on the fundamental question confronting the industry: How can we work …

Download: How to Choose a CRO: Success factors

Cecilia FrostegÃ¥rd-Sundquist, Head of Global Clinical Operations, Swedish Orphan Biovitrum gave a presentation at Clinical Outsourcing World Europe 2013 on How to choose a CRO – success factors for small companies to engage with both large and small CROs. Download the presentation and learn: Key success factors for selection of CRO What core competencies do you need to make sure …